Dentsply Sirona (XRAY) Earnings Analysis

Dentsply Sirona (XRAY) delivered mixed results in Q2 FY2026 on revenue of $898.0M versus the $889.9M estimate (-4.1% YoY) and EPS of $0.52. The next Dentsply Sirona (XRAY) earnings date is Nov 5, 2026. Below is the full Dentsply Sirona earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Dentsply Sirona (XRAY) Earnings Analysis — key stats

Next earnings dateNov 5, 2026
Latest reported quarterQ2 FY2026
Earnings verdictMixed
EPS beat rate4 of last 8 (quarters above estimate)
Avg next-day move±12.1% (over the last 8 reports)
Post-earnings directionUp 2 / Down 6 (of the last 8 reports)
Implied move (next report)±7.7% (options-derived · into Nov 5, 2026)
Institutional ownership114.2% (13F as of 2026-06-30)
Top 10 holders55.2% (of shares outstanding)
Insider activity5 buys / 1 sells (recent Form 4 filings)
Revenue$898.0M (vs $889.9M est · +0.9% surprise · -4.1% YoY)
EPS$0.52 (vs $0.35 est · +49.4% surprise · -178.3% YoY)
Share price$9.41 (-0.9%)
Market cap$1.9B

Dentsply Sirona (XRAY) Earnings Analysis — beat / miss history

QuarterRevenueEPSEPS surpriseNext-day moveVerdict
Q3 FY2026$898.0M vs $889.9M est$0.52 vs $0.35 est+49.4%-12.0%Mixed
Q2 FY2026$880.0M vs $841.8M est$0.27 vs $0.28 est-3.6%-0.5%Mixed
Q1 FY2026$961.0M vs $926.2M est$0.27 vs $0.28 est-3.6%+14.7%Mixed
Q4 FY2025$904.0M vs $927.1M est$0.37 vs $0.45 est-17.8%-11.4%Miss
Q3 FY2025$936.0M vs $904.6M est$0.52 vs $0.50 est+4.0%-5.3%Beat
Q2 FY2025$879.0M vs $920.2M est$0.43 vs $0.29 est+48.3%+15.6%Mixed
Q1 FY2025$905.0M vs $901.3M est$0.26 vs $0.47 est-44.7%-12.0%Mixed
Q4 FY2024$951.0M vs $937.0M est$0.50 vs $0.48 est+4.2%-25.5%Mixed

Top institutional holders

Holder% outstandingSharesValueQoQ change
Blackrock, INC.13.4%26.7M$283.4M+38.7%
Fuller & Thaler Asset Management, INC.6.4%12.7M$134.7M-0.7%
Vanguard Portfolio Management LLC5.9%11.8M$125.0M+11.9%
Aqr Capital Management LLC5.2%10.5M$110.2M+163.8%
State Street Corp4.6%9.3M$98.5M+28.2%
Vanguard Capital Management LLC4.5%9.0M$96.0M+0.5%
Lazard Asset Management LLC4.1%8.3M$87.7M+23.1%
Ariel Investments, LLC4.0%8.0M$85.2M+25.7%
Southpoint Capital Advisors LP3.5%7.0M$74.3M-30.0%
Cooke & Bieler LP3.5%6.9M$73.5M-11.2%

Recent insider transactions

InsiderRoleDateTypeSharesValue
MAZELSKY JONATHAN JAYdirector2026-09-30Buy3K—
Fortson John C.officer: EVP & CFO2026-08-10Buy104K$1.3M
Fortson John C.officer: EVP & CFO2026-08-10Buy24K—
Frohning Andrea L.officer: SVP, CHRO2026-08-07Sell802$9720
Fortson John C.officer2026-07-20Other0—
MAZELSKY JONATHAN JAYdirector2026-06-30Buy3K—
MAZELSKY JONATHAN JAYdirector2026-06-12Buy10K$101400
Barton-Brobst Lindi Reneofficer: SVP, GC & Secretary2026-06-08Other0—

What you'll find

Frequently asked questions

When is Dentsply Sirona's next earnings date?
Dentsply Sirona's (XRAY) next scheduled earnings date is Nov 5, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Dentsply Sirona (XRAY) beat or miss earnings?
In Q2 FY2026, Dentsply Sirona (XRAY) posted mixed results — revenue of $898.0M versus the $889.9M estimate (+0.9% surprise) and EPS of $0.52 versus $0.35 expected (+49.4% surprise). Magnisto decodes every Dentsply Sirona (XRAY) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Dentsply Sirona beat earnings estimates?
Over its last 8 reported quarters, Dentsply Sirona (XRAY) beat Wall Street EPS estimates 4 times, most recently a mixed result in Q3 FY2026. Magnisto tracks every Dentsply Sirona (XRAY) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Dentsply Sirona stock move after earnings?
Over its last 8 quarterly reports, Dentsply Sirona (XRAY) moved an average of ±12.1% the day after earnings — ranging from -25.5% (Q4 FY2024) to +15.6% (Q2 FY2025). The stock rose after 2 of those 8 reports and fell after 6. Heading into its next report on Nov 5, 2026, options-implied volatility is pricing in a move of roughly ±7.7% (derived). Magnisto tracks the realized post-earnings move for every Dentsply Sirona (XRAY) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Dentsply Sirona?
Institutions hold about 114.2% of Dentsply Sirona's (XRAY) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (13.4%), Fuller & Thaler Asset Management, INC. (6.4%), Vanguard Portfolio Management LLC (5.9%). Magnisto lists Dentsply Sirona's (XRAY) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Dentsply Sirona (XRAY)?
In the most recent Form 4 filings Magnisto tracks, Dentsply Sirona (XRAY) insiders recorded 5 purchases and 1 sale — net buying. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Dentsply Sirona (XRAY) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Dentsply Sirona (XRAY), anchored to the current $9.41 share price, so you can weigh the bull, base and bear cases for Dentsply Sirona side by side.
Is Dentsply Sirona (XRAY) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Dentsply Sirona fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.